EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses

Dinoop Ravindran Menon(University of Colorado Anschutz Medical Campus), Mayumi Fujita(University of Colorado Denver)

Pharmaceuticals

October 26, 2021

10.3390/ph14111081

Cited by 88

Related Papers

Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β

|Journal of Biological Chemistry|2009|292

Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma

|Cancers|2020|28

Downregulated ALDH2 Contributes to Tumor Progression and Targeted Therapy Resistance in Human Metastatic Melanoma Cells

|Cells|2025|4

Human Alpha-1 Antitrypsin Suppresses Melanoma Growth by Promoting Tumor Differentiation and CD8+ T-Cell-Mediated Immunity

|Biomolecules|2026|0